Robert M. Rifkin, MD, FACP
Medical Oncologist / Hematologist
Secondary Location(s)
About Robert M. Rifkin, MD, FACP
Dr. Rifkin is a board-certified medical oncologist and hematologist specializing in malignant and benign hematology, treating blood cancers and disorders. He has an advanced sub-specialty expertise in coagulation disorders, multiple myeloma and biosimilars.
Dr. Rifkin practices evidence-based medicine and follows National Comprehensive Cancer Network (NCCN) guidelines for cancer treatment.
Advanced Practice Providers Working With Dr. Rifkin
Board Certifications
Hematology
Internal Medicine
Medical Oncology
Specialties
- Benign and Malignant Hematology
- Biosimilars
- Bleeding Disorders
- Thrombocytopenia
- Blood Disorders
- Anemia
- Pregnancy-Related Blood Disorders
- Clotting Disorders
- Coagulation
- Hereditary Hemochromatosis
- Hodgkin's Lymphoma
- Iron Deficiency
- Leukemia
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)
- Chronic Lymphocytic Leukemia (CLL)
- Chronic Myeloid Leukemia (CML)
- Multiple Myeloma
- Amyloidosis
- Monoclonal Gammopathy (MGUS)
- Smoldering Multiple Myeloma
- Myeloid Malignancies
- Myeloproliferative Neoplasms
- Polycythemia Vera
- Essential Thrombocytosis
- Primary Myelofibrosis
- Myelodysplastic Syndromes
- Non-Hodgkin's Lymphoma
- Diffuse Large B-Cell Lymphoma
- Follicular Lymphoma
- Peripheral T-Cell Lymphoma and Other T-Cell Lymphomas
- Surgical Clearances
Education
Fellowship
Medical Oncology & Hematology, University of Arizona Health Sciences Center, Tucson, AZ
Residency
Internal Medicine, Presbyterian St. Luke’s Medical Center, Denver, CO
Medical School
University of Colorado School of Medicine, Aurora, CO
Patient Care Philosophy
I stress continuity of care and access to state-of-the-art therapies and treatments. It’s essential to rapidly develop therapies and provide them to patients.
